Topics

Sofinnova’s Maha Katabi says it’s a misnomer to believe that biopharma investing is riskier than medical devices. #BBHIC2019pic.twitter.com/yH5UPHE3Xv

14:00 EDT 1 May 2019 | Brad Loncar

Sofinnova’s Maha Katabi says it’s a misnomer to believe that biopharma investing is riskier than medical devices.

Original Article: Sofinnova’s Maha Katabi says it’s a misnomer to believe that biopharma investing is riskier than medical devices. #BBHIC2019pic.twitter.com/yH5UPHE3Xv

NEXT ARTICLE

More From BioPortfolio on "Sofinnova’s Maha Katabi says it’s a misnomer to believe that biopharma investing is riskier than medical devices. #BBHIC2019pic.twitter.com/yH5UPHE3Xv"

Quick Search